Skip to content

Jeffrey C. Fink, M.D.

NPI 1538119946ActiveIndividual· Internal Medicine, Nephrology· Baltimore, MD

Internal Medicine, Nephrology (M.D.) in Baltimore, Maryland, licensed in MD, with an NPI issued in May 2006. Part D covered 18 prescriptions written in 2024, 100% of them generic. Travere Therapeutics, Inc. reported $3.08 in payments in 2024, mostly education.

Overview

NPI1538119946
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMay 10, 2006
Last updated in NPPESMar 28, 2014

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Nephrology Primary207RN0300XD50777MD

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)18 · 54 30-day fills
Total drug cost$168.26
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$3.08 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Travere Therapeutics, Inc.$3.081

What the 2024 payments were for

  • Education$3.08 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nephrologists in Baltimore

All 176 nephrologists in Baltimore · All nephrologists in Maryland